{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:17:07Z","timestamp":1791980227104,"version":"4.4.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007217","name":"Health Services Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007496","name":"Biomedical Laboratory Research and Development, VA Office of Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AR076766"],"award-info":[{"award-number":["R01 AR076766"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 AR066286"],"award-info":[{"award-number":["R21 AR066286"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jid.2021.02.748","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T01:00:17Z","timestamp":1616461217000},"page":"2151-2160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Highly Multiplexed Mass Cytometry Identifies the Immunophenotype in the Skin of Dermatomyositis"],"prefix":"10.1016","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4889-0818","authenticated-orcid":false,"given":"Jay","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8219-4202","authenticated-orcid":false,"given":"Spandana","family":"Maddukuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3377-741X","authenticated-orcid":false,"given":"Yubin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1319-3318","authenticated-orcid":false,"given":"Christina","family":"Bax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3030-5369","authenticated-orcid":false,"given":"Victoria P.","family":"Werth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2021.02.748_bib1","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3389\/fimmu.2017.00528","article-title":"Expansion of CD25-negative forkhead Box P3-Positive T cells during HIV and Mycobacterium tuberculosis infection","volume":"8","author":"Angerami","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2021.02.748_bib2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.4161\/onci.19893","article-title":"Cross-priming for antitumor CTL induced by soluble Ag\u00a0+ polyl:C depends on the TICAM-1 pathway in mouse CD11c(+)\/CD8\u03b1(+) dendritic cells","volume":"1","author":"Azuma","year":"2012","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jid.2021.02.748_bib3","doi-asserted-by":"crossref","first-page":"R104","DOI":"10.1186\/ar4553","article-title":"CD4+CD25-Foxp3+ T cells: a marker for lupus nephritis?","volume":"16","author":"Bonelli","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jid.2021.02.748_bib4","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.3390\/ijms19061738","article-title":"Functional regulation of PPARs through post-translational modifications","volume":"19","author":"Brunmeir","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2021.02.748_bib5","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1365-2133.2004.06144.x","article-title":"Infiltrating cells, related cytokines and chemokine receptors in lesional skin of patients with dermatomyositis","volume":"151","author":"Caproni","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2021.02.748_bib6","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/eji.201646837","article-title":"CD69: from activation marker to metabolic gatekeeper","volume":"47","author":"Cibri\u00e1n","year":"2017","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jid.2021.02.748_bib7","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/bjd.17536","article-title":"The diagnosis and classification of amyopathic dermatomyositis: a historical review and assessment of existing criteria","volume":"180","author":"Concha","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2021.02.748_bib8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev-pathol-020117-043952","article-title":"Type I interferons in autoimmune disease","volume":"14","author":"Crow","year":"2019","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jid.2021.02.748_bib9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.biochi.2004.11.010","article-title":"Phosphorylation of PPARs: from molecular characterization to physiological relevance","volume":"87","author":"Diradourian","year":"2005","journal-title":"Biochimie"},{"key":"10.1016\/j.jid.2021.02.748_bib10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/art.40452","article-title":"Review: cell death, nucleic acids, and immunity: inflammation beyond the grave","volume":"70","author":"Elkon","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2021.02.748_bib11","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jdermsci.2012.11.329","article-title":"Tug-of-war between IFN-\u03b3-producing CD8+T cells and IL-4-producing CD4+T cells destines the severity of muscle injury in dermatomyositis","volume":"69","author":"Fujiyama","year":"2013","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2021.02.748_bib12","first-page":"657","article-title":"Elevated IL-4 and IFN-\u03b3 levels in muscle tissue of patients with dermatomyositis","volume":"31","author":"Giri\u015f","year":"2017","journal-title":"In\u00a0Vivo"},{"key":"10.1016\/j.jid.2021.02.748_bib13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0190-9622(91)70186-6","article-title":"Immunopathologic study of skin lesions in dermatomyositis","volume":"25","author":"Hausmann","year":"1991","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2021.02.748_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/ar2894","article-title":"Identity of mysterious CD4+CD25-Foxp3+cells in systemic lupus erythematosus","volume":"12","author":"Horwitz","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jid.2021.02.748_bib15","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1182\/blood-2007-02-071613","article-title":"The developmental program of human dendritic cells is operated independently of conventional myeloid and lymphoid pathways","volume":"110","author":"Ishikawa","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jid.2021.02.748_bib16","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/01.ATV.19.9.2094","article-title":"Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction","volume":"19","author":"Jackson","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jid.2021.02.748_bib17","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.4049\/jimmunol.1002845","article-title":"TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection","volume":"186","author":"Jelinek","year":"2011","journal-title":"J\u00a0Immunol"},{"issue":"Suppl. 1","key":"10.1016\/j.jid.2021.02.748_bib18","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar2881","article-title":"Overview of the biology of type I interferons","volume":"12","author":"Kalliolias","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jid.2021.02.748_bib19","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1136\/annrheumdis-2018-212988","article-title":"Apoptosis-derived membrane vesicles drive the cGAS-STING pathway and enhance type I IFN production in systemic lupus erythematosus","volume":"77","author":"Kato","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.02.748_bib20","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/bjd.16498","article-title":"Itch in dermatomyositis: the role of increased skin interleukin-31","volume":"179","author":"Kim","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2021.02.748_bib21","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.4049\/jimmunol.178.4.2122","article-title":"Peroxisome proliferator-activated receptor \u03b3 control of dendritic cell function contributes to development of CD4\u00a0+ T cell anergy","volume":"178","author":"Klotz","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2021.02.748_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4049\/jimmunol.0804260","article-title":"Increased antigen cross-presentation but impaired cross-priming after activation of peroxisome proliferator-activated receptor \u03b3 is mediated by up-regulation of B7H1","volume":"183","author":"Klotz","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2021.02.748_bib23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000131751","article-title":"Dermatomyositis","volume":"10","author":"Krathen","year":"2008","journal-title":"Curr Dir Autoimmun"},{"key":"10.1016\/j.jid.2021.02.748_bib24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.4049\/jimmunol.1601999","article-title":"Cutting edge: activation of STING in T cells induces type I IFN responses and cell death","volume":"199","author":"Larkin","year":"2017","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2021.02.748_bib25","doi-asserted-by":"crossref","first-page":"17920","DOI":"10.1074\/jbc.M100156200","article-title":"Profiling changes in gene expression during differentiation and maturation of monocyte-derived dendritic cells using both oligonucleotide microarrays and proteomics","volume":"276","author":"Le Naour","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2021.02.748_bib26","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3389\/fimmu.2018.02061","article-title":"The dual nature of type I and type II interferons","volume":"9","author":"Lee","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2021.02.748_bib27","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/ard.2010.139949","article-title":"Interferon \u03b2 is associated with type 1 interferon-inducible gene expression in dermatomyositis","volume":"70","author":"Liao","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.02.748_bib28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2567.2005.02305.x","article-title":"Interleukin-4 can induce interleukin-4 production in dendritic cells","volume":"117","author":"Maroof","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.jid.2021.02.748_bib29","doi-asserted-by":"crossref","first-page":"6503","DOI":"10.4049\/jimmunol.164.12.6503","article-title":"Peroxisome proliferator-activated receptor-\u03b3 activators inhibit IFN-\u03b3-induced expression of the T cell-active CXC chemokines IP-10, mig, and I-TAC in human endothelial cells","volume":"164","author":"Marx","year":"2000","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2021.02.748_bib30","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1600-0560.2007.00848.x","article-title":"Plasmacytoid dendritic cells are present in cutaneous dermatomyositis lesions in a pattern distinct from lupus erythematosus","volume":"35","author":"McNiff","year":"2008","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.jid.2021.02.748_bib31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/sj.gene.6363791","article-title":"IFNs activate toll-like receptor gene expression in viral infections","volume":"2","author":"Miettinen","year":"2001","journal-title":"Genes Immun"},{"key":"10.1016\/j.jid.2021.02.748_bib32","first-page":"5134760","article-title":"Metabolic plasticity in dendritic cell responses: implications in allergic asthma","volume":"2017","author":"Mishra","year":"2017","journal-title":"J\u00a0Immunol Res"},{"key":"10.1016\/j.jid.2021.02.748_bib33","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1093\/rheumatology\/keaa060","article-title":"Inhibition of mTOR suppresses IFN\u03b1 production and the STING pathway in monocytes from systemic lupus erythematosus patients","volume":"59","author":"Murayama","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jid.2021.02.748_bib34","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.4049\/jimmunol.169.3.1228","article-title":"Dendritic cell immunogenicity is regulated by peroxisome proliferator-activated receptor \u03b3","volume":"169","author":"Nencioni","year":"2002","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2021.02.748_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007633","article-title":"Central memory CD8+ T cells become CD69+ tissue-residents during viral skin infection independent of CD62l-mediated lymph node surveillance","volume":"15","author":"Osborn","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jid.2021.02.748_bib36","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1038\/s41467-020-19918-z","article-title":"Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity","volume":"11","author":"Psarras","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2021.02.748_bib37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/01.CIR.101.3.235","article-title":"Modulation of vascular inflammation in\u00a0vitro and in\u00a0vivo by peroxisome proliferator-activated receptor-\u03b3 activators","volume":"101","author":"Pasceri","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jid.2021.02.748_bib38","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.3389\/fimmu.2017.01666","article-title":"Type I IFNs are required to promote central nervous system immune surveillance through the recruitment of inflammatory monocytes upon systemic inflammation","volume":"8","author":"Peralta Ramos","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2021.02.748_bib39","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0014-5793(98)01514-2","article-title":"Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7","volume":"441","author":"Sato","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jid.2021.02.748_bib40","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nmeth.4391","article-title":"HistoCAT: analysis of cell phenotypes and interactions in multiplex image cytometry data","volume":"14","author":"Schapiro","year":"2017","journal-title":"Nat Methods"},{"key":"10.1016\/j.jid.2021.02.748_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001304","article-title":"Type\u00a0I\u00a0interferon signaling regulates Ly6C(hi) monocytes and neutrophils during acute viral pneumonia in mice","volume":"7","author":"Seo","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jid.2021.02.748_bib42","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.3390\/ijms21082778","article-title":"A\u00a0guide to targeting the endocannabinoid system in drug design","volume":"21","author":"Stasiulewicz","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2021.02.748_bib43","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.4049\/jimmunol.175.9.5681","article-title":"Murine plasmacytoid dendritic cells produce IFN-\u03b3 upon IL-4 stimulation","volume":"175","author":"Suto","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2021.02.748_bib44","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/ncomms2857","article-title":"Toll-like receptor 3 recognizes incomplete stem structures in single-stranded viral RNA","volume":"4","author":"Tatematsu","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2021.02.748_bib45","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1365-2230.2006.02150.x","article-title":"Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis","volume":"31","author":"Wenzel","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jid.2021.02.748_bib46","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1016\/j.jid.2018.03.613","article-title":"605 Study of safety and efficacy of lenabasum, a cannabinoid receptor type 2 agonist, in refractory skin-predominant dermatomyositis","volume":"138","author":"Werth","year":"2018","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.02.748_bib47","doi-asserted-by":"crossref","first-page":"e29161","DOI":"10.1371\/journal.pone.0029161","article-title":"Interferon and biologic signatures in dermatomyositis skin: specificity and heterogeneity across diseases","volume":"7","author":"Wong","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2021.02.748_bib48","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/j.biocel.2012.07.024","article-title":"An active mitochondrial biogenesis occurs during dendritic cell differentiation","volume":"44","author":"Zaccagnino","year":"2012","journal-title":"Int J Biochem Cell Biol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X21010149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X21010149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:46:21Z","timestamp":1762206381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X21010149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0022202X21010149"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2021.02.748","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Highly Multiplexed Mass Cytometry Identifies the Immunophenotype in the Skin of Dermatomyositis","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2021.02.748","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}